Clinical Trials Directory

Trials / Completed

CompletedNCT00453557

Mechanism of Growth Hormone Effects on Adipose Tissue

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (planned)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
Male
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

Growth hormone treatment in humans has been shown to decrease body fat. This study aims to determine what adipose tissue depots are affected by GH and what is the mechanism.

Detailed description

Growth hormone (GH) replacement in GH deficient adults results in an improvement in metabolic status, an increase in lean body mass and a reduction in visceral adiposity. GH might also decrease visceral adiposity in obese adults that are not GH deficient. The objective of the study is to determine the effects of GH on the metabolic syndrome and visceral adiposity in men with low blood levels of IGF-1 and the durability of these effects after stopping GH therapy. We will use a double blind, placebo controlled 6 month intervention trial followed by a blinded follow-up period of 6 months. Thirty non-diabetic middle aged men with central adiposity (BMI \> 27 kg/m2, waist circumference \> 102 cm) will participate.

Conditions

Interventions

TypeNameDescription
DRUGrhGH

Timeline

Start date
1999-04-01
Primary completion
2000-12-01
Completion
2000-12-01
First posted
2007-03-29
Last updated
2016-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00453557. Inclusion in this directory is not an endorsement.